Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS ▾
OVID	Ovid Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.25M	-$17.41M	-240.1%	-13.3%	n/m	n/a
PHIO	Phio Pharmaceuticals Corp. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$8.70M	n/a	-43.2%	n/a	n/a
QNRX	Quoin Pharmaceuticals Ltd. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$15.80M	n/a	-120.5%	n/a	n/a
RVPH	Reviva Pharmaceuticals Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$19.86M	n/a	-229.7%	n/a	n/a
SBFM	Sunshine Biopharma Inc. Manufacturing · Year ended 2025-12-31 · USD	$36.31M	-$5.98M	-16.5%	-25.9%	4.1%	n/a
SKVI	Skinvisible, Inc. Manufacturing · Year ended 2025-12-31 · USD	$20.0K	-$1.06M	n/m	n/a	0.0%	n/a
SYRE	Spyre Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$155.20M	n/a	-21.7%	n/a	n/a
TLPH	Talphera, Inc. Manufacturing · Year ended 2025-12-31 · USD	$28.0K	-$14.29M	n/m	-83.9%	n/a	n/a
URGN	UroGen Pharma Ltd. Manufacturing · Year ended 2025-12-31 · USD	$109.79M	-$153.49M	-139.8%	n/a	21.4%	n/a
VBIO	Valion Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$8.88M	n/a	-52.9%	n/a	n/a
VERU	Veru Inc. Manufacturing · Year ended 2025-09-30 · USD	n/a	-$22.73M	n/a	-124.0%	n/a	n/a
VRDN	Viridian Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$70.85M	-$342.60M	-483.6%	-47.4%	n/m	n/a
VTVT	vTv Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$26.97M	n/a	-41.9%	-100.0%	n/a

Rows per page: 2550 100